TWM471274U - Package structure of snow lotus extractive particle for preventing and improving liver disease, suppressing hypertension, hyperlipidemia, hyperglycemia, losing weight, removing coldness, and beautifying skin - Google Patents
Package structure of snow lotus extractive particle for preventing and improving liver disease, suppressing hypertension, hyperlipidemia, hyperglycemia, losing weight, removing coldness, and beautifying skin Download PDFInfo
- Publication number
- TWM471274U TWM471274U TW102212737U TW102212737U TWM471274U TW M471274 U TWM471274 U TW M471274U TW 102212737 U TW102212737 U TW 102212737U TW 102212737 U TW102212737 U TW 102212737U TW M471274 U TWM471274 U TW M471274U
- Authority
- TW
- Taiwan
- Prior art keywords
- snow lotus
- particles
- preventing
- liver disease
- skin
- Prior art date
Links
- 239000002245 particle Substances 0.000 title claims description 80
- 240000002853 Nelumbo nucifera Species 0.000 title claims description 64
- 235000006508 Nelumbo nucifera Nutrition 0.000 title claims description 64
- 235000006510 Nelumbo pentapetala Nutrition 0.000 title claims description 64
- 208000019423 liver disease Diseases 0.000 title claims description 21
- 206010020772 Hypertension Diseases 0.000 title description 7
- 208000031226 Hyperlipidaemia Diseases 0.000 title description 3
- 201000001421 hyperglycemia Diseases 0.000 title description 3
- 239000002775 capsule Substances 0.000 claims description 30
- 238000004806 packaging method and process Methods 0.000 claims description 28
- 239000011859 microparticle Substances 0.000 claims description 22
- 230000000694 effects Effects 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 12
- 229930003935 flavonoid Natural products 0.000 claims description 7
- 150000002215 flavonoids Chemical class 0.000 claims description 7
- 235000017173 flavonoids Nutrition 0.000 claims description 7
- 238000004090 dissolution Methods 0.000 claims description 6
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 claims description 5
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 claims description 5
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 4
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 4
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 4
- 229940074393 chlorogenic acid Drugs 0.000 claims description 4
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 4
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 4
- 239000011148 porous material Substances 0.000 claims description 4
- 239000010419 fine particle Substances 0.000 claims description 3
- 238000011109 contamination Methods 0.000 claims description 2
- 238000005187 foaming Methods 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims 1
- 244000131522 Citrus pyriformis Species 0.000 claims 1
- 230000004308 accommodation Effects 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 208000014018 liver neoplasm Diseases 0.000 description 11
- 201000007270 liver cancer Diseases 0.000 description 10
- 238000010586 diagram Methods 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 7
- 230000003064 anti-oxidating effect Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- 208000001145 Metabolic Syndrome Diseases 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 2
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 2
- 235000008714 apigenin Nutrition 0.000 description 2
- 229940117893 apigenin Drugs 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003779 heat-resistant material Substances 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 2
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000015256 Chionanthus virginicus Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 241000234271 Galanthus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241001145025 Saussurea involucrata Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 description 1
- 229930190376 scutellarin Natural products 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本創作係關於一種包裝結構,特別是有關於一種用以包裝至少包含一雪蓮萃取微粒,並且,可藉由此包裝結構,令消費者可以口服之方式,將該微粒所含之效性成分送入體內,其可有效地預防與改善肝病、高血壓、高血糖、高血脂及類風濕性關節炎,更具有瘦身、抗氧化、祛寒、美化膚質等功效,藉此達成兼具保健身體與美容之目的的一種裝填雪蓮萃取微粒之包裝結構。The present invention relates to a packaging structure, in particular to a package for containing at least one snow lotus extracting particle, and by means of the packaging structure, the consumer can orally deliver the effective ingredient contained in the particle. Into the body, it can effectively prevent and improve liver disease, high blood pressure, high blood sugar, high blood fat and rheumatoid arthritis, more slimming, anti-oxidation, cold, beautify the skin and other effects, thereby achieving a healthy body A packaging structure for loading snow lotus extract particles with the purpose of beauty.
肝癌為全世界最常見癌症排名之第6名,全球每年有超過600,000件新的肝癌診斷案例,其中,將近有三分之二的案例係源自於亞洲國家,且男性罹患肝癌的機率整體上顯著高於女性,顯示出肝癌之患病率除具有性別差異外,相較於西方國家,東方人之體質較易產生肝病變,導致肝癌的產生,並且,因肝癌早期不容易出現顯著性的不適症狀,一旦出現明顯的自覺症狀時,病情通常已經不輕,故其死亡人數高居所有癌症死亡排名的第三名。Liver cancer ranks 6th in the world's most common cancers, with more than 600,000 new cases of liver cancer diagnosed each year worldwide. Nearly two-thirds of the cases are from Asian countries, and the chances of men suffering from liver cancer are overall. Significantly higher than females, showing that the prevalence of liver cancer, in addition to gender differences, compared with Western countries, the physical constitution of the Oriental is more likely to produce liver disease, leading to the development of liver cancer, and because of the early stage of liver cancer is not easy to appear significant Discomfort, in the case of obvious symptoms, the condition is usually not light, so the death toll is ranked third in all cancer deaths.
對於肝癌的確切成因至今仍不明,依據臨床研究,有65%~80%的肝癌是由B型或C型肝炎病毒所引起,B型或C型肝炎病毒會導致肝臟發炎,經過長期且多次的復發,使得肝臟受到損壞,細胞修復能力降低,進而產生纖維化,再經過增生形成結節,產生了肝硬化,破壞肝臟的循環系統與機能,同時,免疫機制亦受到影響,使得細胞週期失去調控,導致細胞變異而形成癌細胞,轉變成肝癌。此外,亦有研究指出,生活習慣亦是引發肝癌的關鍵因素之一,相較於飲食與作息正常的人,長期熬夜或有酗酒、抽菸習慣的人,其罹患肝癌的機率較高。The exact cause of liver cancer remains unclear. According to clinical studies, 65% to 80% of liver cancers are caused by hepatitis B or C viruses, and hepatitis B or C viruses can cause inflammation of the liver. The recurrence of the liver causes damage to the liver, reduces the ability of cell repair, and then fibrosis, and then forms a nodule through hyperplasia, which produces cirrhosis, destroys the circulatory system and function of the liver, and at the same time, the immune mechanism is also affected, causing the cell cycle to be out of regulation. It causes cell variability to form cancer cells and transform into liver cancer. In addition, studies have also pointed out that lifestyle habits are also one of the key factors that trigger liver cancer. Compared with people with normal diet and routine work, people who stay up late or have alcohol and smoking habits have a higher risk of developing liver cancer.
然而,為了生存,工作忙碌、熬夜、應酬難以避免,又加上速食店充斥,外食比率升高,不規律的生活作息以缺乏運動,使得現代人亦普遍有肥胖、血壓高、血糖高與血脂高的情形,上述之症狀統稱為代謝症候群,致使心血管疾病與糖尿病的患病機率逐年增加。However, in order to survive, busy work, staying up late, entertainment is difficult to avoid, coupled with fast food restaurants, increased food consumption, irregular life and lack of exercise, making modern people generally have obesity, high blood pressure, high blood sugar and In the case of high blood lipids, the above symptoms are collectively referred to as metabolic syndrome, and the risk of cardiovascular disease and diabetes is increasing year by year.
因此,為了讓現代人在忙碌的生活中,也能照顧好身體,廠商紛紛推出了各種保健產品,分別具有不同的保健功能,但大部分的保健產品,主要是由化學合成物,故長期服用,不免會產生安全相關之疑慮,且由於各類保健產品係各具有各自的功效,為了同時照顧肝臟、預防代謝症候群或是其他疾病的產生,即需要不同之保健產品,瓶瓶罐罐,造成消費者的使用不便。Therefore, in order to allow modern people to take care of their bodies in a busy life, manufacturers have introduced various health care products, each with different health functions, but most of the health care products are mainly made of chemical compounds, so they are taken for a long time. It is inevitable that there will be safety-related concerns, and because various health care products have their own effects, in order to take care of the liver, prevent metabolic syndrome or other diseases, different health care products, bottles and cans are required. Consumers are inconvenient to use.
有鑑於此,本創作人即以保護肝臟、預防代謝症候群以及安全性為必要條件,積極地進行研究,並經過多次實驗,終於創作出一種裝填雪蓮萃取微粒之包裝結構,其係裝填有至少包含一雪蓮萃取微粒,可預防與改善肝病、高血壓、高血糖、高血脂及類風濕性關節炎,提升預後的生活品質,此外,還具有瘦身、抗氧化、祛寒、美化膚質等功效,徹底照護人體的健康。In view of this, the creator actively carried out research to protect the liver, prevent metabolic syndrome and safety, and after many experiments, finally created a packaging structure for loading snow lotus extract particles, which was loaded with at least Contains a snow lotus extract particle to prevent and improve liver disease, hypertension, hyperglycemia, hyperlipidemia and rheumatoid arthritis, improve the quality of life of prognosis, in addition, it also has slimming, anti-oxidation, cold, beautifying skin and other effects , thoroughly care for the health of the human body.
本創作之主要目的,在於提供一種裝填雪蓮萃取微粒之包裝結構,其係用以包裝至少包含一雪蓮萃取微粒,且可藉由口服之方式,將該微粒所含的效性成分送入體內,可有效地預防與改善肝病、高血壓、高血糖、高血脂,更具有瘦身、抗氧化、祛寒、美化膚質等功效,同時兼具保健身體與美容之效用。The main purpose of the present invention is to provide a packaging structure for loading snow lotus extract particles, which is used for packaging at least one snow lotus extract microparticle, and the active ingredient contained in the microparticle can be administered into the body by oral means. It can effectively prevent and improve liver disease, high blood pressure, high blood sugar, high blood fat, slimming, anti-oxidation, cold, and beautifying skin. It also has the effect of health care body and beauty.
因此,為了達成本創作之主要目的,本案之創作人提出一種裝填雪蓮萃取微粒之包裝結構,係包括:一殼體,係可容置一微粒,其中,該微粒至少包含一雪蓮萃取微粒;以及複數個微孔,係設於該殼體之表面,且該複數個微孔之孔徑係小於該微粒之粒徑;其中,當使用者將該殼體 浸於一液體中時,其內之該微粒即漸漸溶解,並經由該複數個微孔擴散至該液體中。Therefore, in order to achieve the main purpose of the present invention, the creator of the present invention proposes a packaging structure for loading snow lotus extract particles, comprising: a casing for accommodating a particle, wherein the particle contains at least one snow lotus extracting particle; a plurality of micropores are disposed on a surface of the shell, and a pore size of the plurality of micropores is smaller than a particle diameter of the microparticle; wherein, when the user When immersed in a liquid, the particles therein gradually dissolve and diffuse into the liquid through the plurality of micropores.
並且,為使本創作之裝填雪蓮萃取微粒之包裝結構更具多樣化與多元的使用方式,該裝填雪蓮萃取微粒之包裝結構,係包括:一第一膠囊殼體,具有一第一套合口,且其內側表面係具有一突點;以及一第二膠囊殼體,具有一第二套合口,該第二套合口可與該第一套合口相對套合,且該第一膠囊殼體之該突點可抵靠該第二膠囊殼體之外側表面,使得該第一膠囊殼體與該第二膠囊殼體穩固地扣合在一起;以及一第二容置空間,係於該第一膠囊殼體與該第二膠囊殼體扣合在一起後所形成,並用以容置一微粒,其中,該微粒至少包含一雪蓮萃取微粒,且該雪蓮萃取微粒之粒徑係介於為0.6公釐至5公釐之間。Moreover, in order to make the packaging structure of the snow lotus extract particles of the present invention more diversified and multi-purpose, the packaging structure of the snow lotus extract particles comprises: a first capsule shell having a first set of mouths, And the inner surface of the first capsule has a protrusion; and the second capsule housing has a second sleeve, the second sleeve is opposite to the first sleeve, and the first capsule is The protrusion may abut the outer side surface of the second capsule shell such that the first capsule shell and the second capsule shell are firmly fastened together; and a second accommodating space is attached to the first capsule The shell is formed by being fastened together with the second capsule shell, and is configured to receive a particle, wherein the particle comprises at least one snow lotus extract particle, and the particle size of the snow lotus extract particle is 0.6 mm. To 5 mm.
〔本創作〕[this creation]
1‧‧‧裝填雪蓮萃取微粒之包裝結構1‧‧‧Package structure for loading snow lotus extract particles
2‧‧‧微粒2‧‧‧Particles
11‧‧‧殼體11‧‧‧Shell
12‧‧‧複數個微孔12‧‧‧Multiple micropores
13‧‧‧外包裝13‧‧‧Overpack
3‧‧‧膠囊3‧‧‧ capsules
31‧‧‧第一膠囊殼31‧‧‧First capsule shell
311‧‧‧第一套合口311‧‧‧ first set of joints
321‧‧‧第二套合口321‧‧‧Second set of joints
32‧‧‧第二膠囊殼體32‧‧‧Second capsule housing
33‧‧‧容置空間33‧‧‧ accommodating space
4‧‧‧錠劑4‧‧‧Lies
第一圖係本創作之一種裝填雪蓮萃取微粒之包裝結構之第一實施例的立體圖;第二圖係本創作之第一實施例的示意圖;第三A圖係本創作之第一實施例被製成長方體的示意 圖;第三B圖係本創作之第一實施例被製成球體的示意圖;第三C圖係本創作之第一實施例被製成錐體的示意圖;第三D圖係本創作之第一實施例被製成多邊體的示意圖;第四A圖係本創作之第二實施例的第一示意圖;第四B圖係本創作之第二實施例的第二示意圖;第五A圖係微粒被壓製成三角形錠型態樣;第五B圖係微粒被壓製成圓形錠型態樣;第五C圖係微粒被壓製成四角形錠型態樣;第五D圖係微粒被壓製成蜆狀錠型態樣;以及第六圖係本創作之第三實施例的分解圖。The first drawing is a perspective view of a first embodiment of a packaging structure for loading snow lotus extracted particles of the present invention; the second drawing is a schematic view of the first embodiment of the present creation; the third embodiment is the first embodiment of the present creation Schematic representation of the cuboid Figure 3 is a schematic view showing the first embodiment of the present invention being made into a sphere; the third C diagram is a schematic view of the first embodiment of the creation being made into a cone; the third diagram is the first An embodiment is a schematic diagram of a polygonal body; a fourth A diagram is a first schematic diagram of a second embodiment of the present creation; a fourth diagram B is a second schematic diagram of a second embodiment of the present creation; The particles are pressed into a triangular ingot shape; the fifth B is a microscopic ingot; the fifth C is pressed into a quadrilateral ingot; the fifth D is pressed into a microparticle. An ingot-shaped form; and a sixth figure is an exploded view of a third embodiment of the present creation.
為了能夠更清楚地描述本創作所提出之一種裝填雪蓮萃取微粒之包裝結構,以下將配合圖式,詳盡說明本創作之較佳實施例。In order to more clearly describe the packaging structure of the snowdrop extracting particles proposed by the present invention, a preferred embodiment of the present invention will be described in detail below with reference to the drawings.
請同時參閱第一圖與第二圖,分別係本創作之一種裝填雪蓮萃取微粒之包裝結構之第一實施例的立體圖與示意圖。如第一圖與第二圖所示,本創作之裝填雪蓮萃取微粒之包裝結構1係包括:一殼體11以及複數個微孔12;其中,該殼體11係可容置一微粒2,且該微粒2至少 包含一雪蓮萃取微粒,且該雪蓮萃取微粒之粒徑係介於為0.6公釐至5公釐之間;而該複數個微孔12係設於該殼體11之表面,且該複數個微孔12之孔徑係小於該微粒之粒徑;如此,當使用者將該殼體11浸於一液體中時,其內之該微粒2即漸漸溶解,並經由該複數個微孔12擴散至該液體中。此外,該殼體11更可容置有碳酸氫鈉與檸檬酸,以加速該微粒2於該液體中的溶解速度,並使其於溶解過程中產生發泡的效果。在本創作中,雪蓮萃取微粒之表面係粗糙表面,以增加人體之吸收率;此外,本創作人還發現,當該等雪蓮萃取微粒之粒徑係為1.2公釐至4.6公釐時,達預防與改善肝病、降三高、瘦身、祛寒及美化膚質之吸收率的效果為最佳。Please refer to the first figure and the second figure at the same time, which are respectively a perspective view and a schematic view of a first embodiment of a packaging structure for loading snow lotus extract particles. As shown in the first and second figures, the packaging structure 1 for loading the snow lotus extract particles of the present invention comprises: a casing 11 and a plurality of micropores 12; wherein the casing 11 is capable of accommodating a particle 2, And the particles 2 are at least A snow lotus extracting microparticle is included, and the snow lotus extracting microparticles have a particle diameter of between 0.6 mm and 5 mm; and the plurality of micropores 12 are disposed on the surface of the shell 11 and the plurality of micropores The pore size of the pores 12 is smaller than the particle diameter of the microparticles; thus, when the user immerses the shell 11 in a liquid, the microparticles 2 therein gradually dissolve and diffuse through the plurality of micropores 12 to the In the liquid. In addition, the casing 11 can accommodate sodium bicarbonate and citric acid to accelerate the dissolution rate of the microparticles 2 in the liquid and to cause foaming during dissolution. In this creation, the surface of the snow lotus extract particles is a rough surface to increase the absorption rate of the human body; in addition, the author also found that when the particle size of the snow lotus extract particles is from 1.2 mm to 4.6 mm, It is best to prevent and improve the absorption rate of liver disease, lowering the height, slimming, chilling and beautifying the skin.
繼續地,請參閱第三A圖至第三D圖,分別係本創作之第一實施例被製成長方體、球體、錐體與多邊體的示意圖。如第三A圖至第三D圖所示,該殼體11係為一固體,其形狀可為正方體、長方體、球體、錐體、多邊體其中之一或其組合,並由一耐熱材料所製成,該耐熱材料可為高密度聚乙烯、聚丙烯、聚碳酸酯、鋁箔其中之一或其組合,但不於上述之材料,只要是具有耐熱、無毒、與符合食品容器規範之材料皆可。因此,若欲增加溶解後之該微粒2經該些微孔12擴散至該液體中之擴散速率,使用者可以一攪拌棒或一湯匙攪動該殼體11,亦或是直接以 手搖的方式,搖動盛裝有該液體與該殼體11之一杯體,以加速溶解後之該微粒2的擴散速率,又,該殼體11會隨著該攪拌棒、該湯匙的攪動以及手的搖動而四處移動,故於加速擴散速之同時,亦可提升該微粒2於該液體中之溶解均勻度。Continuing, please refer to the third to third figures, which are schematic views of the first embodiment of the present invention, which are made into a rectangular parallelepiped, a sphere, a cone, and a polygonal body. As shown in the third A to third D drawings, the housing 11 is a solid, and its shape may be one of a cube, a rectangular parallelepiped, a sphere, a cone, a polygon, or a combination thereof, and is made of a heat resistant material. The heat-resistant material may be one of high-density polyethylene, polypropylene, polycarbonate, aluminum foil or a combination thereof, but not the above materials, as long as it is heat-resistant, non-toxic, and conforms to food container specifications. can. Therefore, if the diffusion rate of the dispersed particles 2 through the micropores 12 into the liquid is increased, the user can agitate the housing 11 with a stirring rod or a spoon, or directly In a hand-cranked manner, the cup containing the liquid and the casing 11 is shaken to accelerate the diffusion rate of the particles 2 after dissolution, and the casing 11 is agitated with the stirring rod, the spoon, and the hand. The shaking and moving around, so as to accelerate the diffusion speed, the dissolution uniformity of the particles 2 in the liquid can also be improved.
請同時參閱第四A圖與第四B圖,分別係本創作之第二實施例的第一示意圖與第二示意圖。如第四A圖與第四B圖所示,由於本創作之該殼體11係直接與使用者欲食用之液體接觸,故基於衛生與安全的考量,該裝填雪蓮萃取微粒之包裝結構1更可包括一外包裝13,其可容置一個或多個該殼體11,以將該殼體11與外在環境隔絕,避免汙染,達到防塵與防菌之效果;其中,該外包裝13可製成一袋體或一瓶體。撕開該袋體或打開該瓶體,即可順利取出該殼體11,使用者可依照需求,取出一定數量的殼體11,並直接進行沖泡。Please refer to FIG. 4A and FIG. 4B at the same time, which are respectively a first schematic diagram and a second schematic diagram of the second embodiment of the present invention. As shown in FIG. 4A and FIG. 4B, since the housing 11 of the present invention is directly in contact with the liquid to be consumed by the user, the packaging structure of the snow lotus extraction microparticles is more based on hygiene and safety considerations. An outer package 13 can be included, which can accommodate one or more of the housings 11 to isolate the housing 11 from the external environment to avoid contamination and achieve dustproof and antibacterial effects; wherein the outer package 13 can Made into a bag or a bottle. The housing 11 can be smoothly taken out by tearing the bag or opening the bottle, and the user can take out a certain number of the housings 11 according to the requirements and directly perform brewing.
再者,該雪蓮萃取微粒係萃取自雪蓮之紫色花蕊分生組織培養物(Purple Pistil Tissue Culture,PPTC),且萃取製程中所選用的雪蓮來源為一生長於天山的雪蓮。雪蓮為菊科鳳毛菊屬植物(Saussureu involucrata Kar.et Kin),又名雪荷花,為多年生草本,是唯一能在雪線上生長的大型草本植物,生長在海拔3000米以上的雪山石縫之中,主要分佈於新疆境內的天山山脈、阿勒泰山山脈和昆侖山 脈。而該雪蓮萃取微粒之萃取方法為:以正丁醇作為萃取溶劑,並將其與由乾燥之雪蓮所製成之微粒進行反應;接著,進行分離製程以去除正丁醇,即得該雪蓮萃取微粒,其中,該雪蓮萃取微粒至少包含類黃酮、綠原酸及紫丁香苷。Furthermore, the snow lotus extract particles are extracted from the Purple Pistil Tissue Culture (PPTC) of the snow lotus, and the snow lotus selected for use in the extraction process is a snow lotus grown in the Tianshan Mountains. Saussurea involucrata Kar.et Kin, also known as snow lotus, is a perennial herb. It is the only large herb that can grow on the snow line. It grows in snow-capped seams above 3,000 meters above sea level. Among them, the Tianshan Mountains, the Altay Mountains and the Kunlun Mountains are mainly distributed in Xinjiang. pulse. The extraction method of the snow lotus extract particles is: using n-butanol as an extraction solvent, and reacting with the particles prepared from the dried snow lotus; and then performing a separation process to remove n-butanol, thereby obtaining the snow lotus extract The microparticles, wherein the snow lotus extract particles comprise at least flavonoids, chlorogenic acid and syringin.
承上述,類黃酮為水溶性,依據結構的不同可分為黃酮類(Flavones)、黃酮醇類(Flavonols)、異黃酮類(Isoflavones)、黃烷酮類(Flavanols)、花青素(Anthocyanin)等五大類,是天然的抗氧化劑,其抗氧化能力分別是維生素E的50倍以及維生素C的20倍,被公認為世界上最強的抗氧化劑,此外,類黃酮亦具有易被人體吸收、無蓄積性作用、能清除體內自由基之特性,故服用類黃酮可有效抑制低密度脂蛋白的氧化,進而預防粥狀動脈硬化的產生以及降低血脂,此外,亦可防止自由基破壞關節內的組織,保護關節,並可提升膠質生成的能力以及舒緩發炎,可有效預防與改善類風濕性關節炎。According to the above, flavonoids are water-soluble, and can be classified into Flavones, Flavonols, Isoflavones, Flavanols, Anthocyanin depending on the structure. The five major categories are natural antioxidants. Their antioxidant capacity is 50 times that of vitamin E and 20 times that of vitamin C. It is recognized as the world's strongest antioxidant. In addition, flavonoids are easily absorbed by the body. It has the function of accumulating and clearing free radicals in the body, so taking flavonoids can effectively inhibit the oxidation of low-density lipoprotein, thereby preventing the production of atherosclerosis and lowering blood lipids. In addition, it can prevent free radicals from damaging tissues in the joints. It protects joints and enhances the ability to produce gelatin and soothes inflammation, which can effectively prevent and improve rheumatoid arthritis.
同樣地,綠原酸亦具有極佳地抗氧化與清除自由基之功效,其結構中具有多個氫氧基,該些氫氧基在人體內可形成氫自由基,並與體內之羥基自由基和超氧陰離子等自由基作用,有效消除與抑制上述之自由基的活性,減少自由基對組織的破壞,進而達當保護血管、降低血脂、預防血栓與抗衰老等目的。此外,紫丁香苷已知係為一種 很強的抗肝毒藥物,其可恢復微粒體之酵素系統的活性及抑制脂質的過氧化作用,更可促進肝毒物代謝並改善其肝功能,故可作為保護肝臟之有效成份,另,亦有動物實驗發現,紫丁香苷具有降低血糖功能,可提升葡萄糖轉換成肝糖儲存之效率。Similarly, chlorogenic acid has excellent antioxidant and scavenging effects, and has a plurality of hydroxyl groups in its structure. These hydroxyl groups can form hydrogen radicals in the human body and are free to hydroxyl groups in the body. Free radicals such as radicals and superoxide anions effectively eliminate and inhibit the above-mentioned free radical activity, reduce the damage of free radicals to tissues, and thus achieve the purpose of protecting blood vessels, lowering blood lipids, preventing thrombosis and anti-aging. In addition, syringin is known as a kind It is a strong anti-drug drug, which can restore the activity of the microsomal enzyme system and inhibit the lipid peroxidation. It can also promote liver toxic metabolism and improve liver function, so it can be used as an effective component to protect the liver. Animal experiments have found that syringin has the function of lowering blood sugar and improving the efficiency of glucose conversion into glycogen storage.
該雪蓮萃取微粒除具有上述之成份外,更含有胺基酸、傘型花內酯、東莨菪素、芹菜素、谷甾醇及秋水仙鹼其中之一種或兩種以上混合物;其中,胺基酸可有效地調節人體酸鹼度,增強人體免疫力及抗疲勞;傘型花內酯具有極佳的抗菌、降壓、鎮靜、解痙作用;東莨菪素可祛風、消炎、止痛和祛痰,對治療慢性支氣管炎具有極佳效果;芹菜素亦為類黃酮之一種,具有平滑肌解痙和抗胃潰瘍作用;谷甾醇可降低血壓與減少肝中的膽固醇;以及秋水仙堿則可有效抑制癌細胞的增長,已被使用於臨床治療,尤以對乳腺癌的療效最佳,對皮膚癌、白血病亦具有一定的療效。The snow lotus extracting microparticles further comprise, in addition to the above components, one or a mixture of two or more of amino acid, umbelliferone, scutellarin, apigenin, sitosterol and colchicine; wherein, the amino acid It can effectively regulate the body's pH and enhance human immunity and anti-fatigue; Umbelliferone has excellent antibacterial, antihypertensive, sedative and antispasmodic effects; Dongqiu can be hurricane, anti-inflammatory, analgesic and expectorant, It has excellent effects in the treatment of chronic bronchitis; apigenin is also a kind of flavonoids, which has smooth muscle spasm and anti-gastric ulcer effect; sitosterol can lower blood pressure and reduce cholesterol in the liver; and colchicine can effectively inhibit cancer cells. Growth has been used in clinical treatment, especially for breast cancer, and has a certain effect on skin cancer and leukemia.
因此,當使用者食入至少包含該雪蓮萃取微粒,該雪蓮萃取微粒經由小腸吸收後,其所含之各成份即可發揮各自之功效,改善使用者之體質,有效預防與改善肝病、高血壓、高血糖、高血脂等代謝症候群及類風濕性關節炎,提升預後的生活品質,此外,還具有瘦身、抗氧化、祛寒、降低癌症發生機率等功效,徹底照護人體的健 康。Therefore, when the user ingests at least the snow lotus extract particles, the snow lotus extract particles are absorbed through the small intestine, and the components contained therein can exert their respective effects, improve the user's constitution, and effectively prevent and improve liver disease and hypertension. Hyperglycemia, hyperlipidemia and other metabolic syndromes and rheumatoid arthritis, improve the quality of life of prognosis, in addition, it also has the effects of slimming, anti-oxidation, cold, reducing the incidence of cancer, and thoroughly protect the health of the human body. Kang.
由於,該雪蓮萃取微粒包含有多種具抗氧化作用之成份,其可有效清除與抑制自由基的活性,避免細胞或組織受到傷害,提升細胞的活性與改善代謝,更可抵禦紫外線引起皮膚內離子的游離,兼具抗衰老與美白防曬的功效,因此,該微粒2除了可以該裝填雪蓮萃取微粒之包裝結構1進行裝填與包裝,以供使用者直接口服之外,亦可應用於外用之彩妝品與保養品。於製程中,可在該微粒2內添加賦形劑,例如:防腐劑、抗氧化劑、螯合劑、滲透劑、潤滑劑、增稠劑、以及結合劑其中之一或其組合,改變其物理性或化學性,使其可添加於凝膠狀、水包油型乳化狀或油包水型乳化狀的劑型等之彩妝品與保養品,令使用者以可塗抹的方式,直接將該雪蓮萃取微粒導入皮膚中,提升細胞的活性,有效防止老化、抵抗紫外線的攻擊,使肌膚永保青春與白晳。Because the snow lotus extract particles contain various anti-oxidation components, which can effectively remove and inhibit free radical activity, avoid damage to cells or tissues, enhance cell activity and improve metabolism, and resist ultraviolet rays to cause intradermal ions. The detachment has the functions of anti-aging and whitening sunscreen. Therefore, the microparticle 2 can be filled and packaged for the user to directly fill the packaging structure 1 of the snow lotus extract microparticles, and can also be applied to the external makeup. Products and skin care products. In the process, an excipient such as a preservative, an antioxidant, a chelating agent, a penetrating agent, a lubricant, a thickener, and a binder may be added to the microparticles 2 to change the physical properties thereof. Or chemically added to make cosmetics and skin care products such as gel-like, oil-in-water emulsified or water-in-oil emulsified dosage forms, so that the user can directly apply the snow lotus extract in a smudgeable manner. The particles are introduced into the skin to enhance the activity of the cells, effectively preventing aging and resisting the attack of ultraviolet rays, so that the skin is always youthful and clear.
請同時參閱第二圖、第五A圖至第五D圖,其中,第五A圖至第五D圖分別係微粒被壓製成三角形、圓形、四角形與蜆狀錠型態樣。如第一圖、第二圖、第五A圖至第五D圖所示,於此需補充說明的是,該微粒2亦可經由加壓之方式製成一錠劑4,並以該錠劑4之型式被裝填於該殼體11中,其中,該錠劑4可被壓製成圓形錠型、橢圓形錠型、三角形錠型、四角形錠型、蜆狀錠型、中空 圓形錠型其中之一或其組合。並且,為製得品質較佳之該錠劑4,同樣地,可於該微粒2中添加賦形劑,提升其均勻性、穩定性或改善不良氣味、口感等。Please refer to the second figure, the fifth A picture to the fifth D picture at the same time, wherein the fifth A picture to the fifth D picture are respectively formed into a triangular, circular, quadrangular and 锭-shaped ingot shape. As shown in the first figure, the second figure, the fifth A picture to the fifth D figure, it should be additionally noted that the particle 2 can also be made into a tablet 4 by pressurization, and the ingot is used. The type of the agent 4 is loaded in the casing 11, wherein the tablet 4 can be pressed into a circular ingot shape, an elliptical ingot shape, a triangular ingot shape, a quadrangular ingot shape, a serpentine ingot type, and a hollow shape. One of or a combination of round ingots. Further, in order to obtain the tablet 4 having a better quality, an excipient can be added to the fine particles 2 to improve the uniformity, stability, or improvement of bad odor, mouthfeel, and the like.
接著,請參閱第六圖,係本創作之第三實施例的分解圖。本創作之裝填雪蓮萃取微粒之包裝結構亦可製成一膠囊3,如第六圖所示,該膠囊3係包括:一第一膠囊殼體31,具有一第一套合口311;一第二膠囊殼體32,具有一第二套合口321,其可與該第一套合口311相對套合,並以緊配合的方式扣合在一起,使得該第一膠囊殼體31與該第二膠囊殼體32穩固地扣合在一起,其中,該第一套合口311之外徑係小於該第一膠囊殼體31後段之外徑,且該二套合口321之內徑則與該第一套合口311之外徑相同;以及一容置空間33,係於該第一膠囊殼體31與該第二膠囊殼體32扣合在一起後所形成,並用以容置一微粒2,且該微粒2至少包含一雪蓮萃取微粒,且該雪蓮萃取微粒之粒徑係介於為0.6公釐至5公釐之間。Next, please refer to the sixth drawing, which is an exploded view of the third embodiment of the present creation. The package structure of the snow lotus extraction microparticles of the present invention can also be made into a capsule 3, as shown in the sixth figure, the capsule 3 includes: a first capsule shell 31 having a first sleeve 311; a second The capsule housing 32 has a second sleeve 321 which can be oppositely sleeved with the first sleeve 311 and fastened together in a tight fit so that the first capsule shell 31 and the second capsule The outer diameter of the first sleeve 311 is smaller than the outer diameter of the rear portion of the first capsule shell 31, and the inner diameter of the two sleeves 321 is the same as the first sleeve. The outer diameter of the joint 311 is the same; and an accommodating space 33 is formed after the first capsule shell 31 and the second capsule shell 32 are fastened together, and is used for accommodating a particle 2, and the particle 2 comprising at least one snow lotus extracting microparticle, and the snow lotus extracting microparticles have a particle size of between 0.6 mm and 5 mm.
承上述,該第一膠囊殼體31與該第二膠囊殼32於相互嵌合後,其總長為18.8~22.3 mm,而該容置空間33之容量為0.4~0.7 ml。另,置於該容置空間33內之該微粒2,其所包含之該雪蓮萃取微粒的詳細成份內容、各成份之功效與作用機制等皆同於前述之實施例,故於此不再多述。In the above, after the first capsule shell 31 and the second capsule shell 32 are fitted to each other, the total length is 18.8-22.3 mm, and the capacity of the accommodating space 33 is 0.4-0.7 ml. In addition, the fine particles 2 placed in the accommodating space 33, the detailed component content of the snow lotus extracting particles, the functions and action mechanisms of the components, and the like are the same as the foregoing embodiments, and thus no more Said.
在本創作中,雪蓮萃取微粒係藉由該預防與改善肝病、降三高、瘦身、祛寒及美化膚質的雪蓮萃取微粒之包裝結構,可使得消費者以口服之方式,將該微粒所含的效性成分送入體內,有效地預防與改善肝病、高血壓、高血糖、高血脂,更具有瘦身、抗氧化、祛寒、美化膚質等功效,同時兼具保健身體與美容之效用。In this creation, the snow lotus extract microparticles are made up of the packaging structure of the snow lotus extract particles which prevent and improve liver disease, lowering the height, slimming, chilling and beautifying the skin, so that the consumer can orally use the microparticles. Containing the effective ingredients into the body, effectively prevent and improve liver disease, high blood pressure, high blood sugar, high blood fat, more slimming, anti-oxidation, cold, beautify the skin and other effects, while also having the effect of health care body and beauty .
經由上述,本創作之裝填雪蓮萃取微粒之包裝結構係已同時被完整說明;然而,必須加以強調的是,上述之詳細說明係針對本創作可行實施例之具體說明,惟該實施例並非用以限制本創作之專利範圍,凡未脫離本創作技藝精神所為之等效實施或變更,均應包含於本案之專利範圍中。Through the above, the packaging structure of the snow lotus extraction particles of the present invention has been fully described at the same time; however, it should be emphasized that the above detailed description is specific to the presently feasible embodiment, but the embodiment is not used. Limitation of the scope of the patents of this creation, and equivalent implementations or changes without departing from the spirit of the invention, shall be included in the scope of the patent in this case.
1‧‧‧裝填雪蓮萃取微粒之包裝結構1‧‧‧Package structure for loading snow lotus extract particles
11‧‧‧殼體11‧‧‧Shell
12‧‧‧複數個微孔12‧‧‧Multiple micropores
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102212737U TWM471274U (en) | 2013-07-05 | 2013-07-05 | Package structure of snow lotus extractive particle for preventing and improving liver disease, suppressing hypertension, hyperlipidemia, hyperglycemia, losing weight, removing coldness, and beautifying skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102212737U TWM471274U (en) | 2013-07-05 | 2013-07-05 | Package structure of snow lotus extractive particle for preventing and improving liver disease, suppressing hypertension, hyperlipidemia, hyperglycemia, losing weight, removing coldness, and beautifying skin |
Publications (1)
Publication Number | Publication Date |
---|---|
TWM471274U true TWM471274U (en) | 2014-02-01 |
Family
ID=50550826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW102212737U TWM471274U (en) | 2013-07-05 | 2013-07-05 | Package structure of snow lotus extractive particle for preventing and improving liver disease, suppressing hypertension, hyperlipidemia, hyperglycemia, losing weight, removing coldness, and beautifying skin |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWM471274U (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108464500A (en) * | 2018-03-13 | 2018-08-31 | 武春风 | A kind of dietary composition of auxiliary adjustment hypertension |
CN110063961A (en) * | 2019-06-02 | 2019-07-30 | 吉林农业大学 | A kind of new application of acanthopanax senticosus saponins B |
-
2013
- 2013-07-05 TW TW102212737U patent/TWM471274U/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108464500A (en) * | 2018-03-13 | 2018-08-31 | 武春风 | A kind of dietary composition of auxiliary adjustment hypertension |
CN110063961A (en) * | 2019-06-02 | 2019-07-30 | 吉林农业大学 | A kind of new application of acanthopanax senticosus saponins B |
CN110063961B (en) * | 2019-06-02 | 2022-07-12 | 吉林农业大学 | New application of eleutheroside B |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220118064A1 (en) | Multi-supplement compositions | |
KR101275660B1 (en) | Compositions and methods for the sustained release of beta-alanine | |
AU682880B2 (en) | Soft-shelled gelatin encapsulated particles | |
CN105995846A (en) | Heat clearing and lung moistening sunflower seeds and preparation method thereof | |
CN101559033A (en) | Herbal medicine flower foam shower agent and skin care capsule | |
CN101703123A (en) | Medlar gingko health-care and health-preserving tea and preparation method thereof | |
JP4642135B1 (en) | Beauty set for improving sagging and beauty method using the same | |
TWM471274U (en) | Package structure of snow lotus extractive particle for preventing and improving liver disease, suppressing hypertension, hyperlipidemia, hyperglycemia, losing weight, removing coldness, and beautifying skin | |
CN105983016A (en) | Medicine composition containing silibinin | |
CN104432030A (en) | Health food for maintaining beauty and keeping young | |
CN108042651A (en) | A kind of sub- broken wall composition of chrysanthemum medlar and its preparation method and application | |
CN108065359A (en) | A kind of collagen protein health protection food | |
CN103356899B (en) | Medicament for treating menopausal syndrome and preparation method thereof | |
CN104324081A (en) | Corydalis tuber superfine powder and preparation method and application thereof | |
CN104367482A (en) | Preparation method of curcumin flexible liposome mask | |
CN203486330U (en) | Packaging structure filled with saussurea involucrata extracted particles | |
CN105495595A (en) | Pearl containing buccal tablets and preparation method | |
CN101095440B (en) | Slimming function of kutin tea and method for manufacturing kutin tea micro-pill | |
TWM404712U (en) | Angelica sinensis micro-capsule | |
CN104127406A (en) | Application of dihydromyricetin in preparing inhibitor for liver cell oxidative damage | |
CN103893697B (en) | Traditional Chinese medicine and health care product composition with functions of reducing blood lipid and resisting oxidation and preparation method thereof | |
WO2016053955A1 (en) | Vitamin d-containing nutritional supplements | |
CN105770134A (en) | Traditional Chinese medicine for treating hyperlipemia | |
JP2005350431A (en) | Caffeine composition and its use | |
TWM474516U (en) | Packaging structure of ginseng extract particles for lowering blood glucose, blood pressure, and blood lipid and whitening skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4K | Annulment or lapse of a utility model due to non-payment of fees |